William Blair & Company’s Treace Medical Concepts TMCI Stock Holding History

William Blair & Company’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.2K	Buy	10,846 +364	+3%	+$1K	﹤0.01%	1787
2026 Q1	$14K	Buy	10,482 +402	+4%	+$801	﹤0.01%	1811
2025 Q4	$24.7K	Hold	10,080	–	–	﹤0.01%	1716
2025 Q3	$67.6K	Hold	10,080	–	–	﹤0.01%	1604
2025 Q2	$59.3K	Hold	10,080	–	–	﹤0.01%	1584
2025 Q1	$84.6K	Hold	10,080	–	–	﹤0.01%	1524
2024 Q4	$75K	Hold	10,080	–	–	﹤0.01%	1559
2024 Q3	$58.5K	Sell	10,080 -8,675	-46%	-$55.7K	﹤0.01%	1609
2024 Q2	$125K	Buy	+18,755	New	+$152K	﹤0.01%	1478

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

William Blair & Company's TMCI Position: Q2 2026 in Review

William Blair & Company increased its Treace Medical Concepts (TMCI) stake by 3.5% in Q2 2026, buying an estimated $1K and bringing the position to 10,846 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

William Blair & Company first reported a position in TMCI in Q2 2024 and has held it in 9 quarters since. The position peaked at $125K in Q2 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

William Blair & Company held 10,846 shares of Treace Medical Concepts worth $43.2K as of Q2 2026.
William Blair & Company bought 364 Treace Medical Concepts shares in Q2 2026, an estimated $1K.
Treace Medical Concepts made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1787 holding.
William Blair & Company first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 9 quarters since.
William Blair & Company's Treace Medical Concepts position peaked at $125K in Q2 2024.
116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.